Altimmune (ALT) Receivables - Other (2016 - 2025)

Altimmune (ALT) has disclosed Receivables - Other for 11 consecutive years, with $700000.0 as the latest value for Q3 2025.

  • Quarterly Receivables - Other rose 133.33% to $700000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $700000.0 through Sep 2025, up 133.33% year-over-year, with the annual reading at $400000.0 for FY2024, 300.0% up from the prior year.
  • Receivables - Other for Q3 2025 was $700000.0 at Altimmune, up from $400000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $700000.0 in Q3 2025, with the low at $100000.0 in Q4 2023.
  • Average Receivables - Other over 3 years is $342857.1, with a median of $300000.0 recorded in 2024.
  • The sharpest move saw Receivables - Other skyrocketed 300.0% in 2024, then surged 100.0% in 2025.
  • Over 3 years, Receivables - Other stood at $100000.0 in 2023, then surged by 300.0% to $400000.0 in 2024, then surged by 75.0% to $700000.0 in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $700000.0, $400000.0, and $400000.0 for Q3 2025, Q1 2025, and Q4 2024 respectively.